Bristol-Myers Squibb

YTD

ALL

Trade Bristol-Myers Squibb 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BMY

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies.

CEO

Christopher S. Boerner

CEOChristopher S. Boerner

Employees

32,500

Employees32,500

Headquarters

Princeton, New Jersey

HeadquartersPrinceton, New Jersey

Founded

1933

Founded1933

Employees

32,500

Employees32,500

BMY Key Statistics

Market cap

121.85B

Market cap121.85B

Price-Earnings ratio

17.32

Price-Earnings ratio17.32

Dividend yield

4.15%

Dividend yield4.15%

Average volume

15.15M

Average volume15.15M

High today

$60.93

High today$60.93

Low today

$59.25

Low today$59.25

Open price

$60.00

Open price$60.00

Volume

14.02M

Volume14.02M

52 Week high

$63.33

52 Week high$63.33

52 Week low

$42.52

52 Week low$42.52

Stock Snapshot

With a market cap of 121.85B, Bristol-Myers Squibb(BMY) trades at $59.85. The stock has a price-to-earnings ratio of 17.32 and currently yields dividends of 4.2%.

As of 2026-02-13, Bristol-Myers Squibb(BMY) stock has fluctuated between $59.25 and $60.93. The current price stands at $59.85, placing the stock +1.0% above today's low and -1.8% off the high.

The Bristol-Myers Squibb(BMY)'s current trading volume is 14.02M, compared to an average daily volume of 15.15M.

In the last year, Bristol-Myers Squibb(BMY) shares hit a 52-week high of $63.33 and a 52-week low of $42.52.

BMY News

TipRanks 3d

Bristol-Myers Squibb: Solid Near-Term Execution and 2026 EPS Boost from Eliquis, but Limited Long-Term Visibility Supports Hold Rating

Bernstein analyst Courtney Breen maintained a Hold rating on Bristol-Myers Squibb today and set a price target of $58.00. Valentine's Day Sale - 70% Off Unlock...

Simply Wall St 3d

Bristol-Myers Squibb Is Up 8.7% After Swing To Profit And AI-Focused R&D Push

Bristol-Myers Squibb recently reported its fourth-quarter and full-year 2025 results, showing quarterly revenue of US$12,502 million and a swing from a prior-ye...

Simply Wall St 5d

A Look At Bristol Myers Squibb Valuation After Earnings Beat And Strong 2026 Guidance

Bristol-Myers Squibb (BMY) has moved back into the spotlight after reporting fourth quarter and full year 2025 results, combining higher profitability, flat ann...

Analyst ratings

60%

of 30 ratings

Buy

36.7%

Hold

60%

Sell

3.3%

More BMY News

TipRanks 7d

Reiterating Buy on Bristol-Myers Squibb: Near-Term Outperformance and Pipeline-Driven Upside Support Higher $68 Target

Analyst Jason Gerberry of Bank of America Securities reiterated a Buy rating on Bristol-Myers Squibb, boosting the price target to $68.00. Claim 50% Off TipRank...

People also own

Based on the portfolios of people who own BMY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.